These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7891971)

  • 1. Reliability of visual fields in AGIS.
    Lempert P
    Ophthalmology; 1995 Mar; 102(3):367-8. PubMed ID: 7891971
    [No Abstract]   [Full Text] [Related]  

  • 2. Advanced Glaucoma Intervention Study. 2. Visual field test scoring and reliability.
    Ophthalmology; 1994 Aug; 101(8):1445-55. PubMed ID: 7741836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Automated flicker perimetry in early primary open-angle glaucoma.
    Rota-Bartelink A; Pitt A; Story I; Rait J
    Aust N Z J Ophthalmol; 1996 May; 24(2 Suppl):25-7. PubMed ID: 8811236
    [No Abstract]   [Full Text] [Related]  

  • 4. Signal/noise ratios to compare tests for measuring visual field progression.
    Ernest PJ
    Invest Ophthalmol Vis Sci; 2010 Dec; 51(12):6893; author reply 6893-4. PubMed ID: 21123778
    [No Abstract]   [Full Text] [Related]  

  • 5. Interocular asymmetry of visual field defects in primary open angle glaucoma and primary angle-closure glaucoma.
    Wang JC; Gazzard G; Foster PJ; Devereux JG; Oen FT; Chew PT; Khaw PT; Seah SK
    Eye (Lond); 2004 Apr; 18(4):365-8. PubMed ID: 15069431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Automated Perimetry Under the Microscope: A Re-Examination of Fundamental Assumptions.
    Demirel S
    Invest Ophthalmol Vis Sci; 2015 Nov; 56(12):7224. PubMed ID: 26544790
    [No Abstract]   [Full Text] [Related]  

  • 7. Efficacy of SLO-Microperimetry and Humphrey for evaluating macular sensitivity changes in advanced glaucoma.
    Kulkarni SV; Coupland SG; Stitt DM; Hamilton J; Brownstein JJ; Damji KF
    Can J Ophthalmol; 2013 Oct; 48(5):406-12. PubMed ID: 24093188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An objective evaluation of gaze tracking in Humphrey perimetry and the relation with the reproducibility of visual fields: a pilot study in glaucoma.
    Ishiyama Y; Murata H; Mayama C; Asaoka R
    Invest Ophthalmol Vis Sci; 2014 Nov; 55(12):8149-52. PubMed ID: 25389198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement error of visual field tests in glaucoma.
    Spry PG; Johnson CA; McKendrick AM; Turpin A
    Br J Ophthalmol; 2003 Jan; 87(1):107-12. PubMed ID: 12488273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between asymmetric central corneal thickness and glaucomatous visual field loss within the same patient.
    Sullivan-Mee M; Gentry JM; Qualls C
    Optom Vis Sci; 2006 Jul; 83(7):516-9. PubMed ID: 16840876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of artificial tear administration on visual field testing in patients with glaucoma and dry eye.
    Yenice O; Temel A; Orüm O
    Eye (Lond); 2007 Feb; 21(2):214-7. PubMed ID: 16440009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The validity of screening for open-angle glaucoma in high-risk populations with single-test screening mode frequency doubling technology perimetry (FDT).
    Kamdeu Fansi AA; Li G; Harasymowycz PJ
    J Glaucoma; 2011 Mar; 20(3):167-71. PubMed ID: 20436361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Signal/noise analysis to compare tests for measuring visual field loss and its progression.
    Artes PH; Chauhan BC
    Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4700-8. PubMed ID: 19458326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multicenter comparison study of the Humphrey Field Analyzer I and the Humphrey Field Analyzer II.
    Johnson CA; Cioffi GA; Drance SM; Gaasterland D; Mills RP; Ashburn F; Hnik P; Van Coevorden RE
    Ophthalmology; 1997 Nov; 104(11):1910-7. PubMed ID: 9373125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance of glaucoma progression analysis software in a glaucoma population.
    Arnalich-Montiel F; Casas-Llera P; Muñoz-Negrete FJ; Rebolleda G
    Graefes Arch Clin Exp Ophthalmol; 2009 Mar; 247(3):391-7. PubMed ID: 18982343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantification of congruence between the right and left visual fields.
    Weber J
    Graefes Arch Clin Exp Ophthalmol; 1993 Dec; 231(12):704-10. PubMed ID: 8299978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Visual field progression in glaucoma: what is the specificity of the Guided Progression Analysis?
    Artes PH; O'Leary N; Nicolela MT; Chauhan BC; Crabb DP
    Ophthalmology; 2014 Oct; 121(10):2023-7. PubMed ID: 24878173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Peritest automatic perimeter in screening for glaucomatous visual field defects.
    Douglas GR
    Can J Ophthalmol; 1983 Dec; 18(7):318-20. PubMed ID: 6671150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continued visual field progression in eyes with prior visual field progression in patients with open-angle glaucoma.
    Chen PP; Cady RS; Mudumbai RC; Ngan R
    J Glaucoma; 2010 Dec; 19(9):598-603. PubMed ID: 20179616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methodological variations in estimating apparent progressive visual field loss in clinical trials of glaucoma treatment.
    Katz J; Congdon N; Friedman DS
    Arch Ophthalmol; 1999 Sep; 117(9):1137-42. PubMed ID: 10496384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.